최영진 교수 연구실
article|
인용수 0
·2025
2624P Artificial intelligence (AI)-powered immune phenotype (IP) predicts differential benefit from nivolumab plus ipilimumab (NIVO+IPI) versus sunitinib (SUN) in advanced clear cell renal cell carcinoma (ccRCC)
C.G. Kim, Minkyu Jung, Jae‐Hun Kim, Hee Sang Hwang, Mao Jimin, G. Park, Young Jin Choi, S-H. Beom, Sun Young Rha, Saeam Shin, Jia-Lin Lee, Seung Kew Yoon, Beung‐Chul Ahn, Seok‐Geun Lee, Y.M. Cho, Jae Hyoung Park, Il Park
IF 65.4Annals of Oncology
키워드
IpilimumabNivolumabSunitinibClear cell renal cell carcinomaRenal cell carcinomaKidney cancerImmunotherapyImmune system